Viewing Study NCT05544812


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2025-12-26 @ 11:07 AM
Study NCT ID: NCT05544812
Status: UNKNOWN
Last Update Posted: 2022-09-21
First Post: 2022-09-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer
Sponsor: Xijing Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module